A giant congratulations to the co-founder of the IMS society Hassan Serhan to receiving a $5M+ grant from the Department of Defense to fund Phase 1/2a trial of Carthronix's 1st in class small molecule CX-011 for the pain management and cartilage regeneration in patients with mild to moderate knee osteoarthritis.
